Assistant Professor, Medicine, Perelman School of Medicine
Oncology
Dr. Angela R. Bradbury, MD
|
|
Give Review
Dr. Angela R. Bradbury is an expert in the field of Oncology. She studied medicine at Medical University of South Carolina College of Medicine. She received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Doctor Angela R. Bradbury, MD is a published doctor. She has 30 publications published. The most current publication "Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study." She accepts Medicare payments and is registered with Medicare.gov.
Publications
- The LEGACY Girls Study: Growth and development in the context of breast Cancer family history.
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
- Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer.
- Are Patients With Cancer Less Willing to Share Their Health Information? Privacy, Sensitivity, and Social Purpose.
- Prevalence of mutations in a panel of breast Cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast Cancer.
- Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for Cancer susceptibility.
- Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing.
- Human Subjects Protection: An Event Monitoring Committee for Research Studies of Girls From Breast Cancer Families.
- Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY study.
- Gene patents and personalized Cancer care: impact of the myriad case on clinical oncology.
- Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
- Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
- Knowledge and perceptions of familial and genetic risks for breast Cancer risk in adolescent girls.
- When parents disclose BRCA1/2 test results: Their communication and perceptions of offspring response.
- A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian Cancer.
- Variants of uncertain significance in breast Cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.
- Mucinous adenoCarcinoma of the ovary.
- Parent opinions regarding the genetic testing of minors for BRCA1/2.
- Controversies in communication of genetic screening results for Cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (A...
- Cancer genetic risk assessment and referral patterns in primary care.
- Controversies in communication of genetic risk for hereditary breast Cancer.
- Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
- Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.
- Genetic susceptibility to breast Cancer.
- How often do BRCA mutation carriers tell their young children of the family's risk for Cancer? A study of parental disclosure of BRCA mutations to minors and young adu...
- Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.
- Development of a communication protocol for telephone disclosure of genetic test results for Cancer predisposition.
- Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
- Learning of your parent''s BRCA mutation during adolescence or early adulthood: a study of offspring experiences.
Schools
Medical University of South Carolina
University Of Chicago Hospitals
Conditions Treated
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Medical University of South Carolina College of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1124057021 | |
| NPPES Provider LastName | BRADBURY | |
| NPPES Provider FirstName | ANGELA | |
| NPPES Provider ZIPCode | 191044204 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology | |
| Total Claim Count | 92.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124057021 |
| Last Name Of The Provider | BRADBURY |
| First Name Of The Provider | ANGELA |
| View All |
Similar Doctors
|
|
Dr. Weijing Sun, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick G. Dold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lainie Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gataree Ngarmchamnanrith, MD |
|
|
Dr. Esha Kaul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hossein Borghaei, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor A. Astsaturov, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nancy L. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara N. Maxwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandon E. Kremer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikram R. Paralkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena Gitelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ursina R. Teitelbaum, MD
This Doctor is OpenDoctor Recommended.
|